Showing results (1501-1510 of 1,560) with videos related to

Sort By:
Pageof 156
Annals of Internal Medicine|January 15, 1995
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial GroupB C Tilley, G S Alarcón, S P Heyse, et al.
Diabetes Care|August 14, 1998
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind studyP A Hollander, S C Elbein, I B Hirsch, et al.
The Journal of Nervous and Mental Disease|September 29, 2000
Temperament and character in women with anorexia nervosaK L Klump, C M Bulik, C Pollice, et al.
Biochimica Et Biophysica Acta|November 30, 2013
Photodynamic activity of the boronated chlorin e6 amide in artificial and cellular membranesYuri N Antonenko, Elena A Kotova, Elena O Omarova, et al.
Tumori|July 22, 2017
Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapyIbrahim Yildiz, Ahmet Bilici, Nuri Karadurmuş, et al.
BMC Complementary and Alternative Medicine|September 8, 2012
Effectiveness Guidance Document (EGD) for acupuncture research - a consensus document for conducting trialsClaudia M Witt, Mikel Aickin, Trini Baca, et al.
Bulletin of Experimental Biology and Medicine|September 20, 2021
Photodynamic Therapy of Melanoma B16 with Chlorin E6 Conjugated with a PSMA-LigandO B Abramova, M A Kaplan, M A Grin, et al.
Journal of Endourology|August 30, 2022
Medium-Term Real-World Outcomes of Minimally Invasive Surgical Therapies for Benign Prostatic Hyperplasia: Water Vapor Thermal Therapy (Rezum) vs Prostatic Urethral Lift (UroLift) in a High-Volume Urban Academic CenterChih Peng Chin, Evan B Garden, Krishna T Ravivarapu, et al.
The Journal of Urology|August 9, 2023
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic HyperplasiaSteven A Kaplan, Jared Moss, Sheldon Freedman, et al.
Pediatric Blood & Cancer|June 21, 2022
Real-world experience in treating pediatric relapsed/refractory or therapy-related myeloid malignancies with decitabine, vorinostat, and FLAG therapy based on a phase 1 study run by the TACL consortiumEric S Schafer, Karen Chao, Alexandra M Stevens, et al.
Pageof 156